Alcon Inc. is a leading global vision care company specializing in the development, manufacture, and marketing of surgical equipment, devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. Originally founded in 1945 and headquartered in Geneva, Switzerland, it operated as a subsidiary of Novartis for nine years before becoming an independent public company in April 2019. Alcon Inc. functions through two primary segments: Vision Care, which includes contact lenses, lens care solutions, and ocular health products under brands like Dailies, Total1, and Air Optix, capturing about one-fourth of the U.S. contact lens market; and Surgical, featuring intraocular lenses, ophthalmic surgical equipment, and consumables such as the Centurion phacoemulsification device for cataract surgeries and IOLs like PanOptix and Vivity. With approximately 25,599 employees, Alcon Inc. maintains one of the largest installed bases of eye surgical equipment worldwide, playing a pivotal role in the healthcare sector, particularly in medical instruments and supplies, by advancing eye health innovations and supporting ophthalmologists and consumers globally.